Blockade of [11C](+)-PHNO binding in human subjects by the dopamine D3 receptor antagonist ABT-925 von Graff-Guerrero, Ariel, Redden, Laura, Abi-Saab, Walid, Katz, David A., Houle, Sylvain, Barsoum, Penny, Bhathena, Anahita, Palaparthy, Ramesh, Saltarelli, Mario D., Kapur, Shitij

Volltext

Safety and Efficacy of ABT-089 in Pediatric Attention-Deficit/Hyperactivity Disorder: Results from Two Randomized Placebo-Controlled Clinical Trials von Wilens, Timothy E., M.D, Gault, Laura M., M.D., Ph.D, Childress, Ann, M.D, Kratochvil, Christopher J., M.D, Bensman, Lindsey, B.S, Hall, Coleen M., M.S, Olson, Evelyn, B.S, Robieson, Weining Z., Ph.D, Garimella, Tushar S., Ph.D, Abi-Saab, Walid M., M.D, Apostol, George, M.D, Saltarelli, Mario D., M.D., Ph.D

Volltext

A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of alpha 4 beta 2 Agonist ABT-894 in Adults with ADHD von Bain, Earle E, Robieson, Weining, Pritchett, Yili, Garimella, Tushar, Abi-Saab, Walid, Apostol, George, McGough, James J, Saltarelli, Mario D

Volltext

A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of α4β2 Agonist ABT-894 in Adults with ADHD von BAIN, Earle E, ROBIESON, Weining, PRITCHETT, Yili, GARIMELLA, Tushar, ABI-SAAB, Walid, APOSTOL, George, MCGOUGH, James J, SALTARELLI, Mario D

Volltext

The scopolamine model as a pharmacodynamic marker in early drug development von Lenz, Robert A., Baker, Jeffrey D., Locke, Charles, Rueter, Lynne E., Mohler, Eric G., Wesnes, Keith, Abi-Saab, Walid, Saltarelli, Mario D.

Volltext

Adaptive, Dose-finding Phase 2 Trial Evaluating the Safety and Efficacy of ABT-089 in Mild to Moderate Alzheimer Disease von Lenz, Robert A, Pritchett, Yili L, Berry, Scott M, Llano, Daniel A, Han, Shu, Berry, Donald A, Sadowsky, Carl H, Abi-Saab, Walid M, Saltarelli, Mario D

Volltext

Divalproex Sodium in Children with Partial Seizures: 12-Month Safety Study von Lenz, Robert A., MD, PhD, Elterman, Roy D., MD, Robieson, Weining Z., PhD, Vigna, Namita V., PhD, Saltarelli, Mario D., MD, PhD

Volltext

Sevoflurane Formulation Water Content Influences Degradation by Lewis Acids in Vaporizers von Kharasch, Evan D., Subbarao, Gowdahalli N., Cromack, Keith R., Stephens, Dennis A., Saltarelli, Mario D.

Volltext

Divalproex Sodium Extended-Release for the Prophylaxis of Migraine Headache in Adolescents: Results of a Stand-Alone, Long-Term Open-Label Safety Study von Apostol, George, Lewis, Donald W., Laforet, Genevieve A., Robieson, Weining Z., Fugate, Julie M., Abi-Saab, Walid M., Saltarelli, Mario D.

Volltext

Efficacy and safety of the novel α4β2 neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind, place... von Apostol, George, Abi-Saab, Walid, Kratochvil, Christopher J., Adler, Lenard A., Robieson, Weining Z., Gault, Laura M., Pritchett, Yili L., Feifel, David, Collins, Michelle A., Saltarelli, Mario D.

Volltext

A Double-Blind, Randomized, Placebo-Controlled Study of the Dopamine D3 Receptor Antagonist ABT-925 in Patients With Acute Schizophrenia von REDDEN, Laura, RENDENBACH-MUELLER, Beatrice, ABI-SAAB, Walid M, KATZ, David A, GOENJIAN, Armen, ROBIESON, Weining Z, YAQIN WANG, GOSS, Sandra L, GRECO, Nicholas, SALTARELLI, Mario D

Volltext

ABT-089 demonstrates efficacy in a human model of cognition and good tolerability in subjects with Alzheimer's disease taking acetylcholinesterase inhibitors von Lenz, Robert A, Garimella, Tushar, Dutta, Sandeep, Locke, Charles, Baker, Jeffrey D, Wesnes, Keith, Maruff, Paul, Abi-Saab, Walid M, Saltarelli, Mario D

Volltext

ABT-089, a neuronal nicotinic receptor partial agonist, reverses scopolamine-induced cognitive deficits in healthy normal subjects von Baker, Jeffrey D, Lenz, Robert A, Locke, Charles, Wesnes, Keith, Maruff, Paul, Abi-Saab, Walid M, Saltarelli, Mario D

Volltext

A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of [alpha]4[beta]2 Agonist ABT-894 in Adults with ADHD von Bain, Earle E, Robieson, Weining, Pritchett, Yili, Garimella, Tushar, Abi-saab, Walid, Apostol, George, Mcgough, James J, Saltarelli, Mario D

Volltext

A randomized, double-blind, placebo-controlled Phase 2 study of α4β2 agonist ABT-894 in adults with ADHD von Bain, Earle, Robieson, Weining, Garimella, Tushar, Abi-Saab, Walid, Apostol, George, Saltarelli, Mario D.

Volltext

Efficacy and safety of the novel [alpha]^sub 4^[beta]^sub 2^ neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit/hyperactivity disorder: a randomiz... von Apostol, George, Abi-saab, Walid, Kratochvil, Christopher J, Adler, Lenard A, Robieson, Weining Z, Gault, Laura M, Pritchett, Yili L, Feifel, David, Collins, Michelle A, Saltarelli, Mario D

Volltext

Efficacy and safety of the novel [α.sub.4][β.sub.2] neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit/ hyperactivity disorder: a randomized, doub... von Apostol, George, Abi-Saab, Walid, Kratochvil, Christopher J, Adler, Lenard A, Robieson, Weining Z, Gault, Laura M, Pritchett, Yili L, Feifel, David, Collins, Michelle A, Saltarelli, Mario D

Volltext

Efficacy and safety of the novel alpha sub(4) beta sub(2) neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit/hyperactivity disorder: a randomized,... von Apostol, George, Abi-Saab, Walid, Kratochvil, Christopher J, Adler, Lenard A, Robieson, Weining Z, Gault, Laura M, Pritchett, Yili L, Feifel, David, Collins, Michelle A, Saltarelli, Mario D

Volltext

“Dry” Sevoflurane and the Falling Sky (or Lack Thereof) von Kharasch, Evan D., Subbarao, Gowdahalli N., Cromack, Keith R., Stephens, Dennis A., Saltarelli, Mario D.

Volltext

Rapid in vitro modulation of [ 3H]hemicholinium-3 binding sites in rat striatal slices von Saltarelli, Mario D., Lowenstein, Pedro R., Coyle, Joseph T.

Volltext